Pharmaceutical

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-based vaccine candidates for monkeypox (Mpox ) prevention.

Sep 19, 2023 - 20:00
BioNTech and CEPI partner to develop Mpox vaccine
BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-based vaccine candidates for monkeypox (Mpox ) prevention.
Read the original article

Tags:

Previous Article

Orexo announces NDA submission to FDA for opioid overdose therapy

Next Article

Pharmanovia announces acquisition of Sanofi’s CNS brands

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA committee back Geron’s blood disorder drug

FDA committee back Geron’s blood disorder drug

Mar 16, 2024

STAT+: For-profit biomedical institute, backed by billionaires, launches in Cambridge to speed drug discovery

STAT+: For-profit biomedical institute, backed by billi...

Jan 14, 2024

FDA approves AstraZeneca’s FASENRA for asthma in children

FDA approves AstraZeneca’s FASENRA for asthma in children

Apr 13, 2024